National Tuberculosis Programme Manual |
Common terms and phrases
active TB amikacin anti-TB drugs anti-TB treatment bacilli BCG vaccination BNTP Botswana Category CHBC chronic clients clinical Community TB continuation phase Cotrimoxazole Date default diagnosis of TB directly observed treatment dose drug resistance drug susceptibility testing drug-resistant TB DST results ensure ethambutol Ethionamide extrapulmonary TB fixed-dose combination fluoroquinolones HCWs health facility health workers HIV infection initial injectable agent intensive phase isoniazid laboratory lymph nodes MDR-TB MDR-TB patients Ministry of Health monitoring months of treatment MOTT Mycobacteria National TB negative positive pulmonary TB pyrazinamide reporting response rifampicin risk sensitivity testing side effects smear microscopy smear result smear-negative sputum Sputum Dispatch Register sputum smear sputum smear-positive sputum specimens streptomycin symptoms tablets tabs 3 tabs TB control TB disease TB in children TB meningitis TB patients TB Register TB treatment Transfer treatment failure treatment outcome treatment regimens tuberculin Tuberculosis Register Tuberculosis Treatment Tuberculosis Treatment Card World Health Organization